Neurostyle Launch Event

Author:
Actoverco
Date:
14 July 2024
HY6A3173

Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company (subsidiary company of Actoverco) announced that Neurostyle, produced in tablet form by Nexus specialists, can be used by both ordinary individuals and those with diabetes who have difficulties with medication injections.

Nexus has distributed new products in the form of tablets, soft gels, and effervescent tablets, and plans to produce and market sachets and oral vials in the near future. She announced plans for a serious entry into the export market for these supplements.

Related Posts

IMGM0506

Visual Report on the Introduction of “gynati” and “prequin”

actonib launch

Visual Report on the Introduction of Actonib and Its application in Dermatology

HY6A3173

Neurostyle Launch Event

nahaleh naraghi

Interview with Nahaleh Naraqi about Actoverco social responsibilities

the Capital Corona Disease Management Operation1

Dr. Zali, Commander of the Capital Corona Disease Management Operation, visited the Actover Group